Several Australians have been recognised for their contributions to global eye health during the past two decades as part of the International Agency for the Prevention of Blindness (IAPB)’s Vision 2020 agenda. Read more
Low carb diet an antidote to type 2 diabetes?
An Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes into remission. Read more
Trachoma elimination deadline gets two-year extension
Australia has failed to meet its commitment to eliminate trachoma by 2020, setting a new deadline of 2022. Read more
Presbyopia eye drop in final stage of clinical development
An ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Read more
Case report links COVID-19 with permanent vision loss
Ophthalmologists have documented what is believed to be the first reported case of permanent loss of visual acuity that may have been induced by SARS-CoV-2, the virus that causes COVID-19. Read more
Roche’s faricimab meets primary endpoint in DME trial
Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME) after it produced a similar effect to Eylea in twin clinical trials, but with half the dosing regimen in several patients. Read more
Zeiss to host APAC January Summit – virtual
Zeiss is hosting its 2021 APAC January Summit this month, featuring live, interactive educational sessions for ophthalmologists and Australia’s own Professor Paul Mitchell. Read more
Aussie firm helping to solve bandwidth issues with smart glasses
Australian-operated company Harvest Technology Group has announced a new agreement to commence proof-of-concept trials with the Belgian producer of industrial smart glasses. Read more
Dispensing wage subsidy ‘back on’ for existing staff after government changes tune
The Federal Government has reversed its decision to restrict a major optical dispensing traineeship wage subsidy to new employees only, reinstating the original criteria that included longer term staff. Read more
MBS Taskforce keeps controversial eye injection proposals in final report
Despite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections and consider allowing nurses and optometrists to perform the procedure in its final report to the Federal Government. Read more